- Location
Lamictal
"-
GlaxoSmithKline Will Stop Paying Doctors to Market Its Drugs at Conferences
Dec 25, 2013GlaxoSmithKline, the British pharmaceutical giant, says it will stop paying doctors to market its drugs at conferences and will no longer reward sales agents whose physician customers write the most prescriptions. These practices are ...
-
The USFDA Has Cleared Actavis's ANDA for Lamotrigine Orally Disintegrating Tablets
Jul 17, 2013The USFDA has cleared Actavis' abbreviated new drug application (ANDA) for Lamotrigine orally disintegrating tablets, 25mg, 50mg, 100mg and 200mg. A generic version of GlaxoSmithKline's Lamictal ODT, the antiepileptic drug is indicated ...
-
FDA Has Approved Labeling Changes to Bristol-Myers Squibb's Reyataz
Feb 19, 2013The US Food and Drug Administration (FDA) has approved labeling changes to Bristol-Myers Squibb's Reyataz (atazanavir), an antiretroviral medication. The label will now include warnings about kidney and gall stones in addition to updated ...
-
GSK Has Announced an Agreement with Aspen Global to Divest Majority of Classic Brands
Nov 30, 2012GlaxoSmithKline (GSK) has announced an agreement with Aspen Global to divest majority of Classic Brands, including 25 non-promoted and genericised products in Australia for approximately £172m in cash. The divested brands include ...
Tags: Valtrex, Lamictal, Timentin, Amoxil, branded and generic pharmaceuticals
